✦ LIBER ✦

Acute and chronic efficacy of felodipine in congestive heart failure

✍ Scribed by P. Agostoni; E. Doria; S. Riva; A. Polese

Book ID: 119123132
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 681 KB
Volume: 30
Category: Article
ISSN: 0167-5273
DOI: 10.1016/0167-5273(91)90128-c

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acute haemodynamic effects of felodipine

Acute haemodynamic effects of felodipine in congestive heart failure

✍ H. Emanuelsson; Å. Hjalmarson; S. Holmberg; F. Waagstein 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 580 KB

Acute and long-term efficacy of perindop

Acute and long-term efficacy of perindopril in severe chronic congestive heart failure

✍ D. Flammang; M. Waynberger; A. Chassing 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 793 KB

Hemodynamic effects of felodipine in con

Hemodynamic effects of felodipine in congestive heart failure

✍ Giorgio Binetti; Stefano Pancaldi; Nadia Giovanelli; Silvana Negroni; Rossella M 📂 Article 📅 1987 🏛 Springer US 🌐 English ⚖ 559 KB

Felodipine in severe chronic congestive

Felodipine in severe chronic congestive heart failure: Acute effects on central hemodynamics and regional blood flow distribution

✍ Giorgio Binetti; Ida Rubino; Elisabetta Varani; Roberto Spadoni; Rossella Maria 📂 Article 📅 1989 🏛 Springer US 🌐 English ⚖ 552 KB

Pharmacokinetics of felodipine after int

Pharmacokinetics of felodipine after intravenous and chronic oral administration in patients with congestive heart failure.

✍ PH Dunselman; B Edgar; AH Scaf; CE Kuntze; H Wesseling 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 972 KB

Central and peripheral haemodynamic resp

Central and peripheral haemodynamic responses to felodipine in congestive heart failure

✍ S. Capewell; C. G. Wathen; A. L. Muir 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 452 KB

Using non-invasive radionuclide techniques, we studied the arterial and venous effects of 0.1 mg/kg oral felodipine in 12 men with heart failure due to ischaemic heart disease aged 37-72 y. All were in New York Heart Association Class II or III, required frusemide 40-120 mg daily and were clinically